Price Cut Ahead

Novo Nordisk is cutting prices for its weight-loss and diabetes drugs, Wegovy and Ozempic. Starting in 2027, you’ll pay $675 per month for these meds. It’s a move that won’t shock many, given the public outcry over pricey prescriptions.

What’s Behind the Price Drop?

Don’t expect a detailed explanation from Novo Nordisk just yet. The Danish pharma firm hasn’t said why it’s slashing prices now. What we do know is that Wegovy and Ozempic have been wildly successful – and expensive. It’s likely the company is trying to stay ahead of the competition and avoid more bad press.